Pharmaceutical companies need to learn to be more realistic about their growth prospects before governments will lift profit- squeezing measures, said a report Friday from business advisory group KPMG. Drugs companies have been giving over-optimistic predictions of growth for some time, prompting governments and regulators to clamp down on the industry, said the survey.
